Skip to main content

Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Remedios Rios Barrera

Remedios Rios Barrera

Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2026

Related news

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

Related professionals

Fco. Javier Aymerich Martínez

Fco. Javier Aymerich Martínez

Senior researcher
Neuroradiology
Read more
Natalia Anglada Masferrer

Natalia Anglada Masferrer

Read more
José David Méndez Corral

José David Méndez Corral

Multidisciplinary Nursing Research Group
Read more
Cristina Aguilera Martin

Cristina Aguilera Martin

Main researcher
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.